KLF5, a new player and new target in the permanently changing set of pancreatic cancer molecular drivers

被引：0
|
作者：
M. V. Zinovyeva
M. B. Kostina
I. P. Chernov
L. G. Kondratyeva
E. D. Sverdlov
机构：
[1] Russian Academy of Sciences,Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry
来源：
Russian Journal of Bioorganic Chemistry | 2016年 / 42卷
关键词：
pancreatic ductal adenocarcinoma; KLF5; carcinogenesis; master genes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Pancreatic cancer is one of the most aggressive tumor types characterized by chemotherapy resistance and high metastatic activity. Recent studies revealed new genes, which are likely to be actively involved in the regulation of the processes occurring in the pancreas, as well as in the development of cancer in this organ. This review is devoted to the description of one of the recently revealed genes, KLF5, which seems to be a promising target for therapeutic intervention in the most widespread type of pancreatic cancer, ductal adenocarcinoma.
引用
收藏
页码：606 / 611
页数：5
相关论文
共 50 条
  • [31] Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer
    Onishi, Hideya
    Katano, Mitsuo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (09) : 2335 - 2342
  • [32] New-onset diabetes as a target for pancreatic cancer screening
    Skrha, P.
    Horinek, A.
    Andel, M.
    Fric, P.
    Skrha, J.
    DIABETOLOGIA, 2016, 59 : S273 - S273
  • [33] Fatty acid synthase: A new therapeutic target for pancreatic cancer
    Vander Steen, Travis
    Ding, Li
    Zhang, Yu
    Kemble, George
    Billadeau, Daniel
    Lupu, Ruth
    CANCER RESEARCH, 2019, 79 (13)
  • [34] Inflammation and pancreatic cancer: disease promoter and new therapeutic target
    Shin Hamada
    Atsushi Masamune
    Tooru Shimosegawa
    Journal of Gastroenterology, 2014, 49 : 605 - 617
  • [35] Tertiary lymphoid structures in pancreatic cancer: a new target for immunotherapy
    Zou, Xinlei
    Guan, Canghai
    Gao, Jianjun
    Shi, Wujiang
    Cui, Yunfu
    Zhong, Xiangyu
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [36] Inflammation and pancreatic cancer: disease promoter and new therapeutic target
    Hamada, Shin
    Masamune, Atsushi
    Shimosegawa, Tooru
    JOURNAL OF GASTROENTEROLOGY, 2014, 49 (04) : 605 - 617
  • [37] Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer
    Hideya Onishi
    Mitsuo Katano
    World Journal of Gastroenterology, 2014, (09) : 2335 - 2342
  • [38] Survivin is a Potential New Therapeutic Target in the Treatment of Pancreatic Cancer
    Ly, Q. P.
    Howell, G.
    Mendick, M.
    Murari, C.
    Laschanzky, S.
    Brattain, M.
    PANCREAS, 2015, 44 (08) : 1394 - 1395
  • [39] Oxidative Stress: A New Target for Pancreatic Cancer Prognosis and Treatment
    Martinez-Useros, Javier
    Li, Weiyao
    Cabeza-Morales, Marticela
    Garcia-Foncillas, Jesus
    JOURNAL OF CLINICAL MEDICINE, 2017, 6 (03)
  • [40] Molecular biology of pancreatic cancer - New aspects and targets
    Schneider, Guenter
    Hamacher, Rainer
    Eser, Stefan
    Friess, Helmut
    Schmid, Roland M.
    Saur, Dieter
    ANTICANCER RESEARCH, 2008, 28 (3A) : 1541 - 1550
12345